Study of Collaboration Between Medical Electroradiology Manipulators and Radiologists in Tumor Imaging Using RECIST 1.1 for Solid Cancer

What this Trial Is About

Researchers are evaluating the collaboration between medical electroradiology manipulators MEMs and radiologists in interpreting imaging scans for solid cancers using the RECIST 1.1 standard. This observational study aims to assess how MEMs contribute to identifying and measuring cancer lesions, helping to reduce radiologists workload and enhance report quality. The study focuses on patients already enrolled in oncology protocols requiring RECIST 1.1-based scan evaluations. The study involves a baseline scan interpreted without the radiologist knowing the patients study status to avoid bias. Then, MEMs conduct a preliminary analysis of the scans, including target and non-target lesions and any new lesions, presenting their findings in a structured format to assist radiologists. This cooperative approach is intended to improve assessment accuracy and speed, with the radiologist validating the MEMs work. The study period lasts up to 24 weeks. Participants will undergo regular imaging evaluations based on their existing cancer protocols. Researchers will assess the quality and accuracy of MEMs pre-filling work, the benefits to both radiologists and MEMs, and any improvements in clinical research associate processes. Outcomes focus on the detection and measurement of lesions and the overall impact of this collaboration on tumor imaging assessments. Participants medical follow-up continues as usual throughout the study.

Study of Radiology Manipulator Work Validation by the Radiologist